insulet.com - PODD Company Value to Revenue Ratio

Public company logo of Insulet (PODD)

Insulet Corporation (PODD) is developing strategic alliances with glucose monitor manufacturers to automate therapy. The price-to-sales ratio confirms this trajectory, while the 3103.44 metric indicates the asset's status. The forecast relies on management's experience in scaling tubeless pumps and the technological moat of the Omnipod system, which creates significant barriers to entry for new market players.

PODD Insulet Corporation: EV/Sales Multiple in the range 11/23/2025 - 11/20/2026

PODD (OmniPod): analytical breakdowns and indicator data

Fundamental valuation:Insulet Corporation PODD
Mass-produced product of Insulet Corp

Insulet Corporation is scaling its global presence by delivering innovative tubeless pumps for diabetics of all ages. This multiple compares the total enterprise value of the business to annual sales volume, excluding the impact of debt load on the final valuation. Analyzing the EV/Sales trend helps determine the extent to which the market is willing to pay a premium for the company's expansion and signals that the asset is overbought when extreme values are reached.

Competitor analysis for Insulet Corporation

BSX (Boston Scientific) - Company Value to Revenue Ratio|EW: EV/Sales Multiple|RMD - Total Company Value-to-Revenue Ratio|ZBH (Zimmer) - EV/Sales Multiple|Company Value to Revenue CooperVision (COO)|EV/Sales Multiple ALGN|Company Value to Revenue Globus Medical, Inc. GMED|EV/Sales Multiple TMDX (transmedics.com)|EV/Sales Multiple Alphatec Holdings ATEC|AORT - Enterprise Value-to-Revenue Ratio|ENOV: Enterprise Value-to-Revenue Ratio|IART (Integra LifeSciences) - Company Value to Revenue|Establishment Labs - Business Value to Revenue|BBNX (iLet Bionic Pancreas) - EV/Sales Multiple|Enterprise Value-to-Revenue Multiple IRADIMED Corp IRMD|Enterprise Value-to-Revenue Ratio Embecta Corp (EMBC)|Tandem Diabetes Care (TNDM) - Enterprise Value-to-Sales Ratio|Axogen Surgical - Company Value to Revenue|EV/Sales Multiple SI-BONE, Inc. SIBN|Orthofix Medical - EV/Sales Multiple|Enterprise Value to Sales Volume BVS|OrthoPediatrics (KIDS) - Enterprise Value-to-Revenue Ratio|Enterprise Value to Sales Volume TMCI (Treace Corp)|Enterprise Value-to-Revenue Ratio blade.com|Company Value to Revenue Carlsmed Inc (CARL)|EV/Sales Multiple RXST|CLPT - Enterprise Value-to-Revenue Multiple|Enterprise Value-to-Revenue Ratio Stereotaxis, Inc. STXS|STIM: Company Value to Revenue Ratio|SGHT: Company Value to Revenue|Orchestra BioMed Inc. - Enterprise Value-to-Revenue Coefficient|ANIK: EV/Sales Multiple|NSPR - Total Company Value-to-Revenue Ratio|ZJYL (Jin Medical) - EV/Sales Multiple|Vivani Medical (VANI) - Total Company Value-to-Revenue Ratio|EV/Sales Multiple XTNT|EV/Sales Multiple n1mtc.com (NMTC)|Modular Medical Inc - Company Value to Revenue|Myomo, Inc (MYO) - Enterprise Value-to-Revenue Multiple|COCH: Company Value to Revenue|Total Company Value-to-Revenue Ratio Vivos Therapeutics VVOS|enVVeno Medical Corp. (NVNO) - Enterprise Value-to-Revenue Ratio|Sintx Technologies - Business Value to Revenue|Enterprise Value-to-Revenue Ratio Tenon Medical Inc.|LFWD: Business Value to Revenue|EV/Sales Multiple AMIX|Enterprise Value-to-Revenue Coefficient IVF|Enterprise Value-to-Revenue Ratio Bone Biologics BBLG|Total Company Value-to-Revenue Ratio axonics.com (AXNX)|BIOL - Enterprise Value-to-Revenue Ratio|Dynatronics (DYNT) - Company Value to Revenue|Paragon 28, Inc. (FNA) - Enterprise Value-to-Revenue Ratio|INVO - Total Company Value-to-Revenue Ratio